Project Completion Report
Please submit through your APEC Secretariat Program Director within 2 months of
project completion.
SECTION A: Project profile
Project number & title:
Time period covered
in report:
HWG 03/111A - APEC Workshop on Influenza Vaccine Policies and
Strategies in Post-Pandemic Era
Date
1/07/2011-31/07/2012
30/8/2012
submitted:
Committee / WG / Fora:
Health Working Group
Project Overseer Name
/ Organization /
Economy:
Prof. Feng-Yee Chang
Centers for Disease Control
Chinese Taipei
SECTION B: Project report and reflection
Briefly answer each of the questions below. Section B should be a maximum of 2-3 pages,
inclusive of the questions and tables provided.
1. Project description: In 3-4 sentences, describe the project and its main objectives.
This project is designed to help member economies to formulate more effective influenza
vaccination policies and strategies in the post pandemic periods and help enhance information
and experience sharing in terms of influenza vaccine policies and strategies through lecture,
group discussion and group report. The workshop was divided into different sessions, including
“Vaccination Policy Formulation”, “Vaccination Program Implementation”, “Vaccine Safety
Monitoring” and “Communication for Vaccination Programme”. Each session focused on a topic
with the view to achieving the objectives set forth for the workshop.
2. Meeting your objectives: Were the proposed objectives of the project met? If so, please
describe how. If not, please include any major changes to the proposed scope of the
project. Please outline any problems you may have encountered that resulted in delays to
the delivery of the activity.
The workshop was held successfully in Taipei on 18-20 July 2012. The workshop gathered 25
delegates from 13 APEC member economies, including Australia, Chile, China, Hong Kong,
Indonesia, Japan, Korea, Malaysia, Papua New Guinea, the Philippines, Thailand, the United
States and Vietnam, and 74 experts from Chinese Taipei. Three key objectives of the project
listed below were achieved at the end of the workshop.
(1) To formulate more effective vaccination policies and strategies through exchange of
information and sharing of experience--- During the workshop, the speeches, presentations
and every participant’s ardent discussion all contributed significantly to the formulation of
better vaccination policies and strategies. The workshop provided a good opportunity and
platform for all participants from the APEC region to exchange and share experience and
information on vaccination policies and strategies through thorough discussion.
(2) To identify the major challenges and constraints in APEC economies’ vaccination programs
and to enhance APEC member economies’ capacity of pandemic preparedness in the postpandemic periods--- The moderators and speakers from WHO Collaborating Centers for
Reference and Research on Influenza, CDC and FDA were invited to share successful
examples and best practices in implementing vaccination programs. And also through the
group discussion and group report, participants were encouraged to share and discuss their
vaccination program with others. It helped participants to identify the major challenges and
constrains in their vaccination programs and enhanced their capacity of pandemic
preparedness in the post-pandemic era.
(3) To create an expert network on formulation and implementation of vaccination policies and
Strategies--- The moderators, speakers, experts and participants’ contact information were
collected and distributed to all participants. Participants can utilize this expert network for
sustained sharing of information and collaboration on researches with others after the
workshop.
3. Evaluation: Describe how you evaluated the project upon completion? Detail the results of
the evaluations conducted, if any (e.g. participant evaluation, peer review of publication,
measurement of indicators, statistics demonstrating use of outputs etc.).
During the group discussion for each session, well-trained instructors were assigned to each
group to lead an effective discussion. The discussion topics and questions were prepared and
included in the group handbook. In order to evaluate participants’ learning and discussion result,
each group was requested to submit a group report and share the group’s findings and
suggestions.
At the end of the workshop, an evaluation survey was conducted to evaluate
speaker/participant satisfaction with the workshop. Not only did most of them consider this
workshop has achieved its objectives through sharing of experience and information on
vaccination policies and strategies, they also gave numerous positive feedbacks concerning the
excellent workshop arrangement and the warm hospitality extended to them by the workshop
organizer.
4. Key findings: Describe the main outputs delivered and any broader outcomes achieved as
a result of this project. (For example have there been any capacity building outcomes,
policy or operational changes, or changes to standards or systems as a result of this
activity?) Describe how project outputs relate to fora/sub fora/working group strategic
and medium-term priorities and strategic priorities. Please provide examples of important
findings or lessons learned arising from the project.
This workshop has proven APEC an excellent platform to gather experts from APEC member
economies to exchange information and share experiences. The sharing of experience and best
practice with the invited speakers and group members facilitated the developing economies in
identifying major challenges and constrains in their economies, thus enhancing their capacity of
pandemic preparedness in the post pandemic period. The participants expressed that the
information they gained from the workshop was very useful. They can use the information
learned to compare the influenza vaccine policies implemented in different economies and figure
out the suitable vaccination policies and strategies for their own economies. In addition, they
expressed that they will apply what they learned during the workshop to further improve and
revise their national pandemic influenza preparedness plans.
Moreover, the expert network established through the workshop allows the developing
economies to consult and exchange information with other experts that are from developed
economies and other international organizations. The participants expressed that the workshop
presented a great opportunity to meet appropriate experts who are knowledgeable in the field of
vaccination policies and strategies. The networking opportunity with other APEC economies was
very fruitful. The participants can keep close contact with one another through the expert network
to exchange suggestion and recommendation after the workshop.
This project is a direct response to the APEC HWG medium term workplan (2010 – 2015) as it
aims to enhance preparedness for and effective management of emerging and re-emerging
infectious diseases, vector-borne diseases, HIV/AIDS and pandemics. The knowledge and
information gained from the workshop enable the participants to make a better preparedness
vaccination plan for future pandemic.
5. Next steps: Describe any follow-up steps or projects that are planned following the
completion of the activity, such as post-activity evaluations or tracer studies planned to
assess the impact of this activity. Have the results of the activity been disseminated to
participants and other stakeholders and how? What are (if any) any flow-on effects from
this activity? How will this activity inform any future APEC activities?
The workshop documents, training materials and expert list were uploaded to the Health
Working Group website after the workshop. Chinese Taipei will pay close attention to the
feedback received from participants and provide them with the necessary assistance on
formulation and implementation of vaccination policies and strategies accordingly.
Moreover, the news of workshop activities and result was released to the public through
Chinese Taipei CDC’s official web site after the workshop. And also the speakers’ speeches will
be uploaded to the Chinese Taipei CDC e-learning website for participants’ further learning.
6. Feedback for the Secretariat: Do you have any suggestions for more effective
management of projects in the future? Any assessment of consultants, experts or
participants that you would like to share? (The Secretariat collates and examines feedback to
identify trends for ongoing evaluation of our project management and/or communications
systems.)
Suggestion: We would like to make a suggestion concerning participants from travel-eligible
APEC member economy applying for APEC funding. As the APEC funded participants’ details
and tasks are completed by organizer and submitted to the APEC Secretariat for funding
approval, to trace the process of APEC funding approval effectively, we would like to suggest
the APEC Secretariat could process the compiling of data, including the applicants’ information,
the date of receiving the itinerary and airfare quotation and the advanced payment approval
date etc., and present the information in a consistent format instead of merely forwarding the
email containing the applicant’s response one by one and the funding progress schedule to the
organizer, making the management of projects more effective.
7. Participant information: Please provide details, where applicable. Insert rows as needed.
Economy
# male
# female
Details
Australia
1
1
Ian Gust, Julianne Quaine
Brunei Darussalam
0
1
Sok King Ong
China
1
1
Meiqi Hu, Haijun Su
Hong Kong, China
1
0
Thomas Ho Fai Tsang
Indonesia
1
1
Arie Bratasena, Sulistya Widada
Japan
1
1
Junko Nakatsuka, Masato Tashiro
Republic of Korea
1
1
Young-Joon Park, Soon-Ryu Seo
Malaysia
0
2
Rohani Jahis, Husna Maizura Ahmad Mahir
Papua New Guinea
1
1
Rosheila Dagina, James Materua Amini
The Philippines
0
3
Cecilia Ladines-Llave, Ma. Luisa Paran, Marlyn Convocar
Thailand
1
1
Charung Muangchana, Suchada Jiamsiri
The United States
2
0
Jonathan Schwartz, Steven Black
Viet Nam
2
0
Hoa Le Kim, Pham Van Hung
39
Chang Chao-Ching, Chang Chia-Chi, Chang Feng-Yee,
Chang Luan-Yin, Chao Yen-Nan, Chen Don-Yun, Chen
Pei-Yu, Chen Po-Yen, Chen Wan-Chin, Cheng An-Hua,
Chi Chin-Sheng, Chiang Yu-Chyn, Chien Hui-Yi, Chih YiChien, Chiu Wen-Ta, Chou Chien-Yu, Chou Jih-Haw,
Chou Yu-Ming, Chu Yu-Roo, Fu Ying-Hsien, Ho ChiKung, Ho Li-Li, Hsiung Chao, Hsiung Hsien-Ya, Hsu
Chien-Ting, Hsu Mei-Ling, Hsu Yu-Fen, Huang Fu-Yuan,
Huang Hsiau-Wen, Huang Shao-Chin, Huang Song-En
Angela, Huang Y. W. Ruby, Hung Min-Nan, Kao ChuanLiang, Ke Yu-Fen, Kuo Hung-Wei, Lee Chia-Chi, Lee
Chia-Lin, Lee Min-Shi, Lin Hui-Chen, Lin Ju-Ru, Lin KuoNing, Lin Tzou-Yien, Liu Ching-Chuan, Liu Ming-Ching,
Liu Ming-Tsan, Liu Wu-Tse, Liu Yi-Lien, Liu Yu-Lun, Lo YiChun, On W.F. Angela, Shieh Chun-Fu, Su Chia-Ping, Su
Ih-Jen, Tang Ren-Bin, Tsai Hsiao-Yun, Tsai Kun-Ju, Tsai
Wei-Hsuan, Tsai Yi-Jen, Tsai Yin-Hua, Tseng Shiu-Ling,
Tu Chih-Tsung, Tzou Meir-Chyun, Wang Joyce, Wang
Ping-Cheng, Wang Wei-Fang, Wei Sung-His, Wu HoSheng, Wu Hsiu, Yang Chin-Hui, Yang Ji-Rong, Yang
Shih-Yan, Yang Shu-Er, Yeh Horng-I
Chinese Taipei
35
7. Outputs: Please provide details, where applicable. Change headings or insert rows as needed.
# planned
# actual
Details
# of workshops / events
# of publications distributed
1
1
50-60
200
APEC Workshop on Influenza Vaccine Policies
and Strategies in Post-Pandemic Era
100 workshop program books and 100 group
handbooks were distributed respectively.
# of CDs distributed
0
0
# of websites created
0
0
Other:
0
100
The workshop information and training materials
were stored in the USB disks and distributed.
SECTION C: Budget
Attach a detailed breakdown of the APEC- provided project budget, including:
 Planned costs (using most recently approved budget figures)
 Actual expenditures
 Variance notes: An explanation of any budget line under- or over-spent by 20% or more.
Items
No. of Units
Unit Rate
Direct Labour
Speaker’s
Honorarium
6 speakers
360
4 speakers
360
3 consultant×2
times＝6 times
70/time
Secretariat
Support
3 assistants×4
months＝12
1200/month
(200hours)
Computer
Engineer
1 person
100/day
×3days＝1
day1
(8 hours)
Temporary
Assistant
5persons×3da
ys＝15
100/day (8
hours)
Consultant
APEC Funding
(USD)
Self Financing
(USD)
Actual
Expenditure
2160
18,060
16,620
1,440
0
420
420
14,400
14,400
300
300
1500
1500
47,760
29,440
11,760
11,440
36,000
18,000
2,160
(3 hours)
Travel
64,723
- Per Diem
(Speakers/Experts)
Taipei-4days
294/day/
10persons
person
-Airfare
(Speakers/Experts)
10 trips to
Taipei(busines
s class)
4,000×6
2,000×6
- Per Diem (only
from travel-eligible
economies)
Taipei-4days
294/person/da
y 4.75days
(4days + 75%
one-off
additional
payment)
30,723
2,200×10
1,000×12
34,000
22 persons
-Airfare (only from
travel-eligible
economies)
22 trips to
Taipei(econom
ic class)
Publication of
report (including
300 copies
Funding
approved and
paid by APEC
Secretariat
3,000
3,000
Items
No. of Units
Unit Rate
APEC Funding
(USD)
Self Financing
(USD)
Actual
Expenditure
8,000
8,000
Local
transportation
1,500
1,500
Photocopying
1,000
1,000
Communications
(Phone/ Fax/ Mail/
Courier)
3,000
3,000
21,000
21,000
$103,320
$83,560
distribution)
Equipment /
Materials
(describe briefly
what is required
and why)
Hosting
Printer,
computer,
photocopier,
LCD projector,
Office supplies
etc.
Conference
room rental,
Meals and
receptions
other
Total
$ 66,883
(Self Financing)
SECTION D: Appendices or additions
Please attach any of the following. This information will help us better understand your project,
support overseers of similar projects and plan for future projects.





List of experts or consultants utilized, with job titles and contact details, gender
disaggregated where possible.
 Please see attached file
List of participants, with job titles and contact details
 Please see attached file
Event agendas
 Please see attached file
Links to any relevant websites or online material (e.g. reports, resources created)
 APEC Health Working Group Website (http://www.apechwg.org/pub/News.asp)
 Chinese Taipei Centers for Disease Control website
(http://www.cdc.gov.tw/info.aspx?treeid=45da8e73a81d495d&nowtreeid=1bd193ed6dabaee6&tid=DF4
FBCF148BC2B8D)
Results of participant feedback or other project evaluation (raw and/or analyzed)


Please see attached file
Any other relevant information or resources that would help us learn more about your
project
 Nil
FOR APEC SECRETARIAT USE ONLY APEC comments: Were APEC project guidelines
followed? Could the project have been managed more effectively or easily by the PO?
List of experts
#
1
Photo
Name
Ian
Position
Gust
Professorial
Fellow
2
Masato
Tashiro
Director
3
Cecilia
Ladines-Llave
Professor
4
Young-Joon
5
Steven
6
Thomas Ho
Fai
7
8
Angela W. F.
Mei-Ling
Park
Black
Tsang
On
Hsu
Organization
Email
Department of
Microbiology and
Immunology, The
University of
Melbourne, Australia
idg@unimelb.edu.au
Telphone
+61-3-83443963
WHO Collaborating
Centre for Reference
and Research on
Influenza;Influenza
mtashiro@nih.go.jp
+81-42-565-2498
Virus Research Center,
National Institute of
Infectious Diseases,
Japan
Department of
Gynecologic Oncology,
University of the
Philippines-Philippine caladinesllave@gmail.com +63-842-0032
General Hospital. Chair,
The Cancer Institute
Foundation, Philippine
Division of Vaccine
Preventable Diseases
Control and National
Medical Officer
Immunization
Programme, Korea
CDC
pahmun@hanmail.net
+82-43-719-7354
Center for Global
Health, University of
Cincinnati Children's
Hospital, USA
stevblack@gmail.com
+1 (510)-2197372
Professor of
Pediatrics
Controller
Centre for Health
Protection , Department
thomas_tsang@dh.gov.hk +852-2961-8889
of Health
Hong Kong SAR
National ADR
Chief Executive Reporting System,
Director
Taiwan Drug Relief
Foundation
Professor
Department of
Journalism, College of
Communication
National Chengchi
University
angela.on@tdrf.org.tw
+886-2-2358-7343
mlshiu@nccu.edu.tw
+886-2-293-87429
Department of Public
Administration,
National Chengchi
University
9
Don-yun
Chen
Professor
10
Feng-Yee
Chang
Director-General
Centers for Disease
fychang@cdc.gov.tw
Control, Chinese Taipei
+886-2-2395-9825
ext:3910
Tzou
Division
Director
Division of Drugs and
New Biotechnology
Products Food and Drug pamctzou@fda.gov.tw
Administration, Chinese
Taipei
+886-2-27878099,
+886-2-27878000
Professor /
Senior
Attending
Physician
Pediatric Department,
Mackay Memorial
Hospital, Chinese
Taipei
+886--2543-3535
ext:2002
11
Meir-Chyun
12
Fu-Yuan
Huang
13
Jih-Haw
Chou
14
Tzou-Yien
Lin
Deputy Minister
Su
National Institute of
Infectious Disease and
Distinguished
Vaccinology, National
Investigator and
Health Research
Director
Institutes, Chinese
Taipei
15
Ih-Jen
donc@nccu.edu.tw
fyhuang@ms2.mmh.org.tw
Deputy
Centers for Disease
jchou@cdc.gov.tw
Director-General Control, Chinese Taipei.
Department of Health,
Chinese Taipei
+886-937816334
+886-2-2394-5203
adphhsu@doh.gov.tw
+886-2-8590-6666
suihjen@nhri.org.tw
971129@nhri.org.tw
+886-6-2083426
List of Participants
Australia
Ian Gust
Current Position: Professor
Organization: Department of Microbiology and Immunology, The University of
Melbourne
E-mail: idg@unimelb.edu.au
Tel: +61-3-83443963
Julianne Quaine
Current Position: Assistant Secretary (Branch Head)
Organization: Health Protection Programs Branch, Office of Health Protection,
Department of Health and Ageing
E-mail: julianne.quaine@health.gov.au
Tel: +61-2-6289-7705
Brunei Darussalam
Sok King Ong
Current Position: Acting Specialist
Organization: Environmental Health Services, Department of Health Services,
Ministry of Health
E-mail: sokking_ong@hotmail.com
Tel: +673-898-2348
China
Meiqi Hu
Current Position: Division Director
Organization: Department of International Cooperation, Ministry of Health
E-mail: humq@moh.gov.cn
Tel: +86-10-68772282
Haijun Su
Current Position: Division Director
Organization: Bureau of Disease Control, Ministry of Health
Tel: +86-10-68792335
Hong Kong, China
Thomas Ho Fai Tsang
Current Position: Controller
Organization: Centre for Health Protection, Department of Health
E-mail: thomas_tsang@dh.gov.hk
Tel: +852-2961-8889
Indonesia
Andi Muhadir
Current Position: Director
Organization: Directorate of Surveillance, Immunization, Quarantine and Matra
Health, Diseases Control and Environmental Health, Ministry of Health
E-mail: a.muhadir@yahoo.com
Arie Bratasena
Current Position: Head
Organization: Sub-directorate of Acute Respiratory Track Infection, Directorate of
Communicable Disease, Ministry of Health
E-mail: arie.bratasena@yahoo.com
Tel: +6221-42873461
Sulistya Widada
Current Position: Head
Organization: Section of Guidance and Evaluation of Immunization, Directorate of
Surveillance, Immunization, Quarantine and Matra Health, Diseases Control and
Environmental Health, Ministry of Health
E-mail: widadasulistya@yahoo.co.id
Tel: +6221-4249024
Japan
Junko Nakatsuka
Current Position: Deputy Director
Organization: Office of Pandemic Influenza Preparedness & Response, Division of
Tuberculosis and Infectious Diseases Control, Health Service Bureau, Ministry of
Health, Welfare and Labour
E-mail: nakatsuka-junko@mhlw.go.jp
Tel: +81-3-3595-3426
Masato Tashiro
Current Position: Director
Organization: WHO Collaborating Centre for Reference and Research on Influenza;
Influenza Virus Research Center, National Institute of Infectious Diseases, Tokyo
E-mail: tashiro@nih.go.jp
Tel: +81-42-565-2498
Republic of Korea
Young-Joon Park
Current Position: Medical Officer
Organization: Division of Vaccine Preventable Diseases Control and National
Immunization Programme, Korea Centers for Disease Control and Prevention
E-mail: pahmun@hanmail.net
Tel: +82-43-719-7354
Soon-Ryu Seo
Current Position: Research Officer
Organization: Chronic Disease Control Division, Korea Centers for Disease Control
and Prevention
E-mail: seos@korea.kr
Tel: +82-43-719-7384
Malaysia
Rohani Jahis
Current Position: Senior Principal Assistant Director
Organization: Disease Control Division, Department of Public Health, Ministry of
Health
E-mail: ohbj@moh.gov.my
Tel: +603-8883-4411
Husna Maizura Ahmad Mahir
Current Position: Public Health Physician/Senior Principal Assistant Director
Organization: Disease Control Division, Department of Public Health, Ministry of
Health
E-mail: drhusna_maizura@moh.gov.my
Tel: +603-8883-4508
Papua New Guinea
Rosheila Dagina
Current Position: Technical Officer
Organization: Disease Surveillance, National Department of Health
E-mail: rdagina@gmail.com; rosheila_dagina@health.gov.pg
Tel: +675-3236179
James Materua Amini
Current Position: Chief Paediatrician
Organization: National Department of Health
E-mail: jmamini@datec.net.pg
Tel: +675-3248200; +675-76826548
The Philippines
Cecilia Ladines-Llave
Current Position: Professor
Organization: Department of Gynecologic Oncology, The Cancer Institute
Foundation, University of the Philippines Manila - Philippine General Hospital Email: caladinesllave@gmail.com
Tel: +63-842-0032
Ma. Luisa Paran
Current Position: Medical Specialist II, Infectious Disease Cluster Head
Organization: Department of Health, Center for Health Development - Cordillera
E-mail: lisaparan@yahoo.com
Tel: +63-74-444-5255
Marlyn Convocar
Current Position: Officer-In-Charge, Director IV
Organization: Department of Health, Center for Health Development - Region
12
E-mail: mconvocar@yahoo.com
Tel: +63-64-421-2373
Chinese Taipei
Chang Chao-Ching
Current Position: Director
Organization: Fifth Branch, Centers for Disease Control
E-mail: 3c@cdc.gov.tw
Tel: +886-7-556-5803
Chang Chia-Chi
Current Position: Officer
Organization: Fourth Division, Centers for Disease Control
E-mail: candyc@cdc.gov.tw
Tel: +886-2-2395-9825 ext:3672
Chang Feng-Yee
Current Position: Director-General
Organization: Centers for Disease Control
E-mail: fychang@cdc.gov.tw
Tel: +886-2-2395-9825 ext:3910
Chang Luan-Yin
Current Position: Professor
Organization: Department of Pediatrics, National Taiwan University Hospital
E-mail: lychang@ntu.edu.tw
Tel: +886-2-2312-3456 ext:71528
Chao Yen-Nan
Current Position: Medical Officer
Organization: Second Division, Centers for Disease Control
E-mail: yennan@cdc.gov.tw
Tel: +886-919-353-175
Chen Don-Yun
Current Position: Professor
Organization: Department of Public Administration, National Cheng-chi University
E-mail: donc@nccu.edu.tw
Tel: +886-2-2939-3091 ext: 51145
Chen Pei-Yu
Current Position: Assistant Technical Specialist
Organization: Vaccine Center, Centers for Disease Control
E-mail: peiyu@cdc.gov.tw
Tel: +886-2-2785-0513 ext:606
Chen Po-Yen
Current Position: Chairman
Organization: Pediatric Infectious Disease, Taichung Veterans General Hospital
E-mail: pychen6368@yahoo.com.tw
Tel: +886-933-189415
Chen Wan-Chin
Current Position: Medical Officer
Organization: First Branch, Centers for Disease Control
E-mail: wanchin@cdc.gov.tw
Tel: +886-2-2395-9825 ext: 5027
Cheng An-Hua
Current Position: Deputy Director Organization: First
Division, Centers for Disease Control
E-mail: anhua@cdc.gov.tw
Tel: +886-2-2395-9825 ext: 3011
Chi Chin-Sheng
Current Position: Assistant Technical Specialist
Organization: Fourth Branch, Centers for Disease Control
E-mail: ggsggstw@cdc.gov.tw
Tel: +886-6-2696211 ext: 102
Chiang Yu-Chyn
Current Position: Section Chief Organization: Public
Health Bureau of Taoyuan County
E-mail: tyhtom@tychb.gov.tw
Tel: +886-3-334-0935 ext: 2100
Chien Hui-Yi
Current Position: Program Coordinator
Organization: First Division, Centers for Disease Control
E-mail: ivy0311@cdc.gov.tw
Tel: +886-2-2395-9825 ext: 3007
Chih Yi-Chien
Current Position: Section Chief
Organization: Fourth Division, Centers for Disease Control
E-mail: chih@cdc.gov.tw
Tel: +886-2-2395-9825 ext: 3665
Chiu Wen-Ta
Current Position: Minister
Organization: Department of Health
Tel: +886-2-8590-6666
Chou Chien-Yu
Current Position: Assistant Technical Specialist
Organization: First Branch, Centers for Disease Control
E-mail: jelly@cdc.gov.tw
Tel: +886-975-030773
Chou Jih-Haw
Current Position: Deputy Director-General
Organization: Centers for Disease Control
E-mail: jchou@cdc.gov.tw
Tel: +886-2-23945203
Chou Yu-Ming
Current Position: Senior Specialist
Organization: Fourth Division, Centers for Disease Control
E-mail: cym@cdc.gov.tw
Tel: +886-2-23959825 ext: 3090
Chu Yu-Roo
Current Position: Division Chief
Organization: Department of Health, Taipei City Government
E-mail: yrchu@health.gov.tw
Tel: +886-966-601615
Fu Ying-Hsien
Current Position: Executive Officer
Organization: Division of Drugs & New Biotechnology Products, Food and Drug
Administration
E-mail: yhfu@fda.gov.tw
Tel: +886-2-2787-7441
Ho Chi-Kung
Current Position: Director General
Organization: Department of Health, Kaohsiung City Government
E-mail: eight@kcg.gov.tw
Tel: +886-7-724-3327
Ho Li-Li
Current Position: Section Chief
Organization: Public Relations Office. Centers for Disease Control,
E-mail: lilyho@cdc.gov.tw
Tel: +886-928-130490
Hsiung Chao
Current Position: Director
Organization: Institute of Population Health Science, National Health Research
Institutes
E-mail: hsiung@nhri.org.tw
Tel: +886-37-246-166 ext:36100
Hsiung Hsien-Ya
Current Position: Nurse
Organization: Public Health Bureau of Miaoli County
E-mail: mlh188@tcmail.doh.gov.tw
Tel: +886-3-7330002 +886-928-975776
Hsu Chien-Ting
Current Position: Contract Staff
Organization: Public Health Bureau of Miaoli County
E-mail: mlh39@tcmail.doh.gov.tw
Tel: +886-037-336781
Hsu Mei-Ling
Current Position: Professor
Organization: Department of Journalism, College of Communication, National
Chengchi University
E-mail: mlshiu@nccu.edu.tw
Tel: +886-2-25433535 ext:2002
Hsu Yu-Fen
Current Position: Technical Specialist
Organization: Epidemic Intelligence Center, Centers for Disease Control
E-mail: yh5@cdc.gov.tw
Tel: +886-3-3937720 ext:1025
Huang Fu-Yuan
Current Position: Professor / Senior Attending Physician
Organization: Pediatric Department, Mackay Memorial Hospital
E-mail: fyhuang@ms2.mmh.org.tw
Tel: +886-2-25433535 ext:2002
Huang Hsiau-Wen
Current Position: Senior Researcher
Organization: Center for Science and Technology, Food and Drug Administration
E-mail: pahshuang@fda.gov.tw
Tel: +886-2-2787-7037
Huang Shao-Chin
Current Position: Assistant Researcher
Organization: Vaccine Center, Centers for Disease Control
E-mail: schuang@cdc.gov.tw
Tel:+886-2-2785-0513ext:742
Huang Song-En Angela
Current Position: Medical Officer
Organization: Field Epidemiology Training Program Offices, Centers for
Disease Control
E-mail:huang.songen@cdc.gov.tw
Tel: +886-919-404373
Huang Y. W. Ruby
Current Position: Executive Officer
Organization: Division of Drugs & New Biotechnology Products, Food and Drug
Administration
E-mail: ruby@fda.gov.tw
Tel: +886-2-2787-7411
Hung Min-Nan
Current Position: Medical Officer
Organization: Fifth Branch, Centers for Disease Control
E-mail: mnhung@cdc.gov.tw
Tel: +886-933-620192
Kao Chuan-Liang
Current Position: Associate Professor
Organization: Department of Clinical Laboratory Sciences and Medical
Biotechnology, National Taiwan University.
E-mail: chuanliang@ntu.edu.tw
Tel: +886-933-128081
Ke Yu-Fen
Current Position: Section Chief
Organization: First Division, Centers for Disease Control
E-mail: kyf@cdc.gov.tw
Tel: +886-2-2395-9825 ext:3057
Kuo Hung-Wei
Current Position: Technical Specialist
Organization: Epidemic Intelligence Center, Centers for Disease Control
E-mail: hwkuo@cdc.gov.tw
Tel: +886-2-3393-5073
Lee Chia-Chi
Current Position: Section Chief
Organization: Public Health Department, New Taipei City Government
E-mail: af9557@ntpc.gov.tw
Tel:+886-2-2257-7155ext:1440
Lee Chia-Lin
Current Position: Technical Specialist
Organization: Fourth Division, Centers for Disease Control
E-mail: lincl@cdc.gov.tw
Tel: +886-2-2391-9880
Lee Min-Shi
Current Position: Associate Investigator
Organization: National Health Research Institutes
E-mail: minshi@nhri.org.tw
Tel: +886-037-246166 ext:35520
Lin Hui-Chen
Current Position: Medical Officer
Organization: Fifth Branch, Centers for Disease Control
E-mail: lhuichen@gmail.com
Tel: +886-952-415076
Lin Ju-Ru
Current Position: Section Chief
Organization: Fourth Branch, Centers for Disease Control
E-mail: angina@cdc.gov.tw
Tel: +886-2395-9825 ext:3670
Lin Kuo-Ning
Current Position: Assistant Director
Organization: Department of Health, Taipei City Government
E-mail: philip56@health.gov.tw
Tel: +886-2-2375-9800 ext:1901
Lin Tzou-Yien
Current Position: Deputy Minister
Organization: Department of Health
Tel: +886-2-8590-6666
Liu Ching-Chuan
Current Position: Director
Organization: Center for Infection Control, National Chengkung University
E-mail: liucc@mail.ncku.edu.tw
Tel: +886-972-002882
Liu Ming-Ching
Current Position: Assistant Technical Specialist
Organization: Sixth Branch, Centers for Disease Control
E-mail: liugem@cdc.gov.tw
Tel: +886-3-8242260
Liu Ming-Tsan
Current Position: Associate Researcher
Organization: Research and Diagnostic Center, Centers for Disease Control
E-mail: mtliu@cdc.gov.tw
Tel: +886-2-26531108
Liu Wu-Tse
Current Position: Professor Emeritus
Organization: National Yang-Ming University
E-mail: wutseliu@gmail.com
Tel: +886-2-2783-4704
Liu Yi-Lien
Current Position: Director General
Organization: Public Health Bureau of Taoyuan County
E-mail: elan0122@yahoo.com.tw
Tel: +886-3-332-4110
Liu Yu-Lun
Current Position: Medical Officer
Organization: Epidemic Intelligence Center, Centers for Disease Control
E-mail: liuyl@cdc.gov.tw
Tel: +886-2-23959825 ext:3103
Lo Yi-Chun
Current Position: Medical Officer
Organization: Field Epidemiology Training Program Offices, Centers for Disease
Control
E-mail:loyichun@cdc.gov.tw
Tel: +886-989-066426
On W.F. Angela
Current Position: Chief Executive Director
Organization: Taiwan Drug Relief Foundation
E-mail: angela.on@tdrf.org.tw Tel: +886-22358-7343
Shieh Chun-Fu
Current Position: Director General
Organization: Public Health Bureau of Lienjang County
E-mail: tsecf@matsuhb.gov.tw
Tel: +886-8-362-5231; +886-937-181506
Su Chia-Ping
Current Position: Medical Officer
Organization: Second Branch, Centers for Disease Control
E-mail: cpsu@cdc.gov.tw
Tel: +886-3-3983394
Su Ih-Jen
Current Position: Director
Organization: National Institute of Infectious Diseases and Vaccinology, National
Health Research Institutes
E-mail: suihjen@nhri.org.tw
Tel: +886-6-2083426, +886-6-2083422ext:65200
Tang Ren-Bin
Current Position: Chairman
Organization: Department of Pediatrics, Taipei Veterans General Hospital
E-mail: rbtang@vghtpe.gov.tw
Tel: +886-966-285123
Tsai Hsiao-Yun
Current Position: Associate Technical Specialist
Organization: Fourth Division, Centers for Disease Control
E-mail: evalyn@cdc.gov.tw
Tel: +886-2-2395-9825 ext:3889
Tsai Kun-Ju
Current Position: Section Head
Organization: Public Health Department, New Taipei City Government
E-mail: ac0592@ms.ntpc.gov.tw
Tel: +886-2-2257-7155 ext:1444
Tsai Wei-Hsuan
Current Position: Contract Staff
Organization: Health Bureau of Keelung City
E-mail: dr8121@klchb.gov.tw
Tel: +886-2-24230181 ext:147
Tsai Yi-Jen
Current Position: Senior Reviewer
Organization: Division of Drugs & New Biotechnology Products, Food and Drug
Administration
E-mail: jytsai@fda.gov.tw
Tel: +886-2-2787-7428
Tsai Yin-Hua
Current Position: Assistant Technical Specialist
Organization: Vaccine Center, Centers for Disease Control
E-mail: yina@cdc.gov.tw Tel:
+886-2-2785-0513 ext:736
Tseng Shiu-Ling
Current Position: Section Chief
Organization: Health Bureau of Keelung City
E-mail: 4138@klchb.gov.tw
Tel: +886-2-2423-0181 ext:141
Tu Chih-Tsung
Current Position: Section Chief
Organization: Third Branch, Centers for Disease Control
E-mail: twujj@cdc.gov.tw
Tel: +886-4-2473-9940 ext:218
Tzou Meir-Chyun
Current Position: Director
Organization: Division of Drugs and New Biotechnology Products, Food and Drug
Administration
E-mail: pamctzou@fda.gov.tw
Tel: +886-2-2787-7400
Wang Joyce
Current Position: Senior Specialist
Organization: Division of Drugs and New Biotechnology Products, Food and Drug
Administration
E-mail: pajoyce@fda.gov.tw
Tel: +886-2-2787-7403
Wang Ping-Cheng
Current Position: Research Assistant
Organization: First Division, Centers for Disease Control
E-mail: pcwang@cdc.gov.tw
Tel: +886-916-935670
Wang Wei-Fang
Current Position: Assistant Technician
Organization: Public Health Bureau of Yilan County
E-mail: B0984@mail.e-land.gov.tw
Tel: +886-3-932-2634 ext: 214
Wei Sung-Hsi
Current Position: Medical Officer
Organization: Third Branch, Centers for Disease Control
E-mail: seal@cdc.gov.tw
Tel: +886-4-2473-9940 ext:203
Wu Ho-Sheng
Current Position: Director
Organization: Research and Diagnostic Center, Centers for Disease Control
E-mail: wuhs@cdc.gov.tw
Tel: +886-2-2653-1377
Wu Hsiu
Current Position: Medical Officer
Organization: First Branch, Centers for Disease Control
E-mail: hsiu@cdc.gov.tw
Tel: +886-2-2395-9825 ext:4055
Yang Chin-Hui
Current Position: Director
Organization: Fourth Division, Centers for Disease Control
E-mail: inf@cdc.gov.tw
Tel: +886-2-239509825 ext:3650
Yang Ji-Rong
Current Position: Assistant Researcher
Organization: Research and Diagnostic Center, Centers for Disease Control
E-mail: ggyang@cdc.gov.tw
Tel: +886-2-2785-0513
Yang Shih-Yan
Current Position: Director
Organization: First Division, Centers for Disease Control
E-mail: yangsy@cdc.gov.tw
Tel: +886-2-2395-9825 ext:3010
Yang Shu-Er
Current Position: Assistant Researcher
Organization: Fourth Division, Centers for Disease Control
E-mail: shuer@cdc.gov.tw
Tel: +886-2-2395-9825 ext:3698
Yeh Horng-I
Current Position: Technical Specialist
Organization: Division of Drugs & New Biotechnology Products, Food and Drug
Administration
E-mail: horngyeh@fda.gov.tw
Tel: +886-2787-7452
Thailand
Charung Muangchana
Current Position: Director
Organization: National Vaccine Institute, Department of Disease Control, Ministry of
Public Health
E-mail: charungm@hotmail.com
Tel: +66-25903196
Suchada Jiamsiri
Current Position: Medical Officer
Organization: Bureau of General Communicable Diseases, Department of Disease
Control, Ministry of Public Health
E-mail: sjiamsiri@post.harvard.edu
Tel: +66-818105664
The United States
Jonathan Schwartz
Current Position: Professor
Organization: State University of New York, New Paltz
E-mail: schwartj@newpaltz.edu
Tel: +1-845-257-2627
Steven Black
Current Position: Professor of Pediatrics
Organization: Center for Global Health, University of Cincinnati Children’s
Hospital
E-mail: stevblack@gmail.com
Tel: +1-510-2197372
Viet Nam
Hoa Le Kim
Current Position: Deputy Director
Organization: Institute of Vaccine and Medical Biologicals (IVAC)
E-mail: lekimhoa@dng.vnn..vn; kimhoaivac@gmail.com
Tel: +84-903-504198
Pham Van Hung
Current Position: Vice Director
Organization: National Institute of Control of Vaccine and Biologicals (NICVB)
E-mail: pvhung@nicvb.org.vn
Tel: +84-4-3559-3014
APEC Workshop on Influenza Vaccine Policies and
Strategies in Post-Pandemic Era
Wednesday, 18 July 2012
Time
09:00-09:30
Subject
Speaker
Registration
Prof. Wen-Ta Chiu
09:30-09:50
Opening Remarks
Minister, Department of Health,
Chinese Taipei
09:50-10:00
Group Photo (Invited Guests)
10:00-10:30
Coffee Break
Keynote Speeches
Prof. Ian Gust
10:30-11:10
Influenza Vaccines in the PostPandemic Period
Professorial Fellow, Department
of Microbiology and Immunology,
The University of Melbourne,
Australia
Vaccination Campaign for
11:10-11:50
Influenza Pandemic in Chinese Director-General, Centers for
Taipei
11:50-13:40
Session I:
Prof. Feng-Yee Chang
Disease Control, Chinese Taipei
Lunch Break
Vaccination Policy Formulation
Moderator: Prof. Ian Gust
Professorial Fellow, Department of Microbiology and Immunology,
The University of Melbourne, Australia
Prof. Tzou-Yien Lin
Deputy Minister, Department of Health, Chinese Taipei
Prof. Don-Yun Chen
Vaccination Policy Formulation: Professor, Department of Public
13:40-14:10
Planning, Refining and
Administration, National
Participating
Chengchi University, Chinese
Taipei
Prof. Masato Tashiro
Lessons Learnt from
14:10-14:40
(HIN1)2009 Influenza
Pandemic for Preparedness
Against Future Pandemics
Director, WHO Collaborating
Centre for Reference and
Research on Influenza. Influenza
Virus Research Center, National
Institute of Infectious Diseases,
Japan
14:40-14:50
Q&A
14:50-15:20
Coffee Break
15:20-16:00
Group Discussion
16:00-17:00
Group Report & Open Discussion
17:00-17:20
Group Photo (All Participants)
18:00-20:00
Welcome Party
Thursday, 19 July 2012
Time
Subject
08:30-09:00
Speaker
Registration
Session II: Vaccination Program Implementation
Moderator: Dr. Thomas Ho-Fai Tsang
Controller, Centre for Health Protection, Department of Health, Hong
Kong, China
Prof. Feng-Yee Chang
Director-General, Centers for Disease Control, Chinese Taipei
Prof. Cecilia Ladines-Llave
Professor, Department of
09:00-09:30
Vaccine Program
Gynecologic Oncology, The
Implementation in Low
Cancer Institute Foundation,
Resource Settings
University of the Philippines
Manila - Philippine General
Hospital, The Philippines
Dr. Young-Joon Park
Medical Officer, Division of
09:30-10:00
Evaluation of Immunization
Campaign Against H1N1
Vaccine Preventable Diseases
Control and National
Immunization Programme, Korea
Centers for Disease Control and
Prevention, Republic of Korea
10:00-10:10
Q&A
10:10-10:40
Coffee Break
10:40-11:20
Group Discussion
11:20-12:20
Group Report & Open Discussion
12:20-13:40
Lunch Break
Session III: Vaccine Safety Monitoring
Moderator: Dr. Meir-Chyun Tzou
Director, Division of Drugs and New Biotechnology Products, Food
and Drug Administration, Chinese Taipei
Prof. Fu-Yuan Huang
Professor, Pediatric Department, Mackay Memorial Hospital,
Chinese Taipei
13:40-14:10
Evaluation of the Risk of
Prof. Steven Black
Adverse Events Following
Professor, Center for Global
Pandemic Influenza Vaccine:
Child Health, University of
The Importance of International Cincinnati Children’s Hospitals,
Collaboration
The United States
Building Vaccine Safety
Monitoring Infrastructure in
Chinese Taipei: Experience
14:10-14:40
from Adverse Events Following
Immunization (AEFI)
Surveillance of Pandemic
Influenza Vaccination
14:40-14:50
Q&A
14:50-15:20
Coffee Break
Dr. Angela W.F. On
Chief Executive Director, Taiwan
Drug Relief Foundation, Chinese
Taipei
15:20-16:00
Group Discussion
16:00-17:00
Group Report & Open Discussion
Friday, 20 July 2012
Time
08:30-09:00
Subject
Speaker
Registration
Session IV: Communication for Vaccination Programme
Moderator: Prof. Ih-Jen Su
Director, National Institute of Infectious Diseases and Vaccinology,
National Health Research Institutes, Chinese Taipei
Dr. Jih-Haw Chou
Deputy Director-General, Centers for Disease Control, Chinese
Taipei
Prof. Mei-Ling Hsu
Risk Communication between
09:00-09:30
Health Scientists/Experts and
the Lay Public
Professor, Department of
Journalism, College of
Communication, National
Chengchi University, Chinese
Taipei
Communications on Influenza
09:30-10:00
Vaccination Program: Pitfalls
and Lessons in Hong Kong
Dr. Thomas Ho Fai Tsang
Controller, Centre for Health
Protection, Department of Health,
Hong Kong, China
10:00-10:10
Q&A
10:10-10:30
Coffee Break
10:30-11:10
Group Discussion
11:10-12:10
Group Report & Open Discussion
Prof. Tzou-Yien Lin
12:10-12:30
Closing Ceremony
Deputy Minister, Department of
Health, Chinese Taipei
Project Title:
APEC Workshop on Influenza Vaccine Policies and
Strategies in Post-Pandemic Era
1. For Moderators & Speakers
a. What were your roles before, during, and after the activity?

After the activity I will conduct better meeting on influenza vaccine deploy plan.

Strategy formulation, program planning, risk communication

Planning and revision of vaccination program in Korea.
b. Do you think the project achieved its objectives? What were the
projects’ results/achievements?

Yes, improved understanding of the regional situation with pandemic of the
planning / vaccination.

Yes. Share information on different solution of each economy so we can learn
and prepare more on vaccine policy and safety.

To find the challenge and identify the problem
c. Were the attendees the most appropriate target group?

Yes. They are knowledgeable and ask the right questions.

Yes, most of them are appropriate.

Most of attendees capable to certain level for the meeting of the workshop.
d. What is your assessment of the overall effectiveness of the project?

High. Great chance of networking with regional partners. Excellent time control
allows ample time for discussion.

This workshop has covered all areas concern about.

High
e. Was there any room for improving the project? If so, how?

Nil

Nil
f. Any other suggestions:

Continued communications / exchanges with regional partners.
 Nil
2. For Participants：
a. How have you or your economy benefited from the project?
 Exchange and share experience with other economies.
 For better preparedness of next pandemic flu.
 To prepare for pandemic influenza in the face, especially in a cross sectoral and
nation
 Sharing with/and learning from other economies in regard to the vaccines polices
and strategies.
 All information in this project useful for FDA and EPI in my economy; to make
vaccination policies in future.
 Yes, I have.
 Lessons learned from experiences of other economies and presentation by the
speakers in various concepts.
 Networking & Sharing of information / knowledge / experience
 We are revising the national plan of pandemic influenza preparedness. I’ll feed-up
to my colleagues what I’ve heard about the experiences of others, and refer when
revising process.
 Yes.
 I learn a lot from workshop also it has a good chance to share the experiences
among APEC economies.
 Greater understanding of comparative pandemic preparedness. Lessons to learn
from the experience of other countries.
 We can compare the influenza vaccine policies between different economies.
 Good
 I learned a lot about how each economy reacted to the influenza pandemic.
 Learn other economies experience.
 Fair.
 We were able to raise issues regarding the pandemic preparedness or response of
our country of address the gaps in its implementation.
 Good.
 Yes.
 Information sharing on influenza vaccine in various economies.
b. What new skills, knowledge, or value have you gained?
 The hospitality shown by Taiwanese is very impressive.
 To learn the vaccination system in Australia, Korea, the Philippines and Thailand.
 Taiwan and Hong Kong’s experience on vaccine campaign.
 Knowledge and realities on the flu vaccine (H1N1).
 In a cross sectoral coordination
 Greater knowledge of SOPs in various economies, the challenge and solution to
vaccine related challenges.
 Management of adverse event of immunization.
 H5N1 vaccine is available
 Introduction of HPV vaccine is undergoing in some places.
 AEPI data analysis and report
 New information updated relates influenza virus strains.
 Safety vaccination program.
 Planning vaccine public engagement.
 Preparedness is key importance.
 Taiwanese are friendly and helpful.
 As APEC members, we should all be intercommunicated, work together as a team,
share information and work toward one goal.
 Experience from other economies.
 Lesson learnt from APEC economies that implementing all flu vaccination.
 Electronic post marketing surveillance of vaccine
 Importance of planning / training on risk communication skills
 Better understanding of how economies deal with pandemic vaccine programs.
 We gained the knowledge about influenza viruses, vaccines and communications.
 The implementation of vaccine in each economy.
 Policy formulation and new risk communication skills.
 Learnt from other economies experience
 I learned about the successes and failures of vaccination programs all around the
world.
c. What, if any, changes do you plan to pursue in your home economy as a
result of the project?
 Assess the need of flu vaccine –epidemiologically.
 Yes.
 Active surveillance for AEFI.
 How to improve pre-pandemic vaccine.
 Building infrastructure in the face of pandemic influenza.
 None so far.
 To improve the implementation on sharing information between FDA, EPI, Media
and manufacture.
 Yes, we will improve the vaccine safety monitoring system.
 Review epidemiological data of influenza
 N/A
 Good working of harmonious relationship with the media.
 Update documents on national influenza pandemic preparedness.
 Sharing and advocacy for training and planning of enhanced surveillance system.
 Better promotion between seasonal influenza vaccination program and success in
pandemic vaccine program.
 Include lay public in the discussion.
 To enhanced the risk communication skills.
 Not sure
 I will share my knowledge with my colleagues.
d. What needs to be done next? How should the project be built upon?
 Should then be a need to introduce influenza vaccine to the general population,
though evaluation must be done and there are few issues need to be considered i.e.
matching, immunization, response etc.
 Infectious disease surveillance for emerging infectious diseases
 Epidemiology and public health policy.
 Capacity building.
 If possible, more keynote speakers can be invited.
 I think should spend more time for group discussion.
 Need to establish an interconnected electronic system to allow for surveillance,
registration and evaluation.
 How to improve pre-pandemic vaccine.
 Stronger international cooperation conveys APEC members built upon trust and
sharing of recourse.
 Review and update of pandemic influenza preparedness as part of overall /general
preparedness plans
 Conduct review meeting on policy/ strategy of flu vaccine.
 Identify representatives of the lay public.
 Sharing experience is great, should do more.
 Set up the implementation scheme for pandemic event.
 Discussion about seasonal influenza vaccine program in the region where there can
be strengthened.
 Vaccine is but one component of pandemic preparedness and response. Expanding
to include other aspects of pandemic response.
 Hold workshops regard other issues like post marketing drug analysis.
e. Is there any plan to link the project’s outcomes to subsequent collective
actions by fora or individual actions by economies?
 As above, outcome shall be presented to the next policy and practice on
immunization.
 Yes
 There are no plans
 Yes. We can do better in 1. Vaccine supply and providing 2. Adverse event data
compiling and analysis.
 Not yet.
 Not sure.
 I think that should be organizing workshop every year for APEC members
opportunity sharing experience.
 Should link to general economy preparedness plans to public health emergencies
(APSED strategy), WHO, WPRO/SEARO.
 APSED meeting
 We’ll try to share and provide feedback to our respective economy.
 Not yet.
 Yes
 To be considered on return to Australia possibility yes.
f. Please use the same scale to rate the project on an overall basis.
[5]
[4]
[3]
(Good)
Result:
60%
[2]
[1]
(Poor)
30%
10%
g. What is your assessment of the overall effectiveness of the project?
 Good
 Objectives attained but effectiveness will be determined after the inputs/outputs
have been properly disseminated to the member economies for utilization.
 This project is very useful.
 Communication, training.
 Good
 Very effective.
 Good
 I think this project successfully.
 Good
 Good meeting/ success meeting/ meet with my needs
 Excellent, all issues on vaccine policy planning and safety covered during workshop.
 Excellent
 Fair
 Good
 Project reached its intended objectives.
 Very useful and effective workshop
 Excellent
 Presentations were very informative.
h. Was the project content: (Check One)
Just Right ___ Too Detailed ___ Not Detailed Enough ___
Result:
85%
0%
15%
i. Please provide any additional comments. How to improve the project, if
any?
 Give more time for the group discussions so that all questions can be answered.
 1. Needs to invite more scholars from academic 2. Epidemiology is not emphasized
for public health policy decision-making 3. Good at group discussion and TaiwanCDC’s coordination 4. Better planning to compile different policies such as school
closures, class suspension in different economies can be compared and concluded.
 None so far.
 The organizer of project should send content of project for all participants before
one or two week.
 Invite more economies, international organizations, NGOs enterprises.
 Have website to put all the materials/surveys. And recommendations to be accessed
by participant/member states.
 I could learn the expediency, policies and implementation of other economies very
much. But I could not provide enough information for the others as I only deal with
pandemic influenza, not general immunization programme.
 Allow more time for discussion and limit to 2 group presentations per session to
save time.
 As noted earlier, expand focus to other aspects of pandemic response and control
such as state-society relations, inter and intra government collaboration, containment
and migration efforts.
 Very well organized. Excellent speakers.